Acticand vaginal tablets is indicated in the treatment and prevention of candida vulvovaginitis and related symptoms, in case of both acute episode (VVC) and relapsing forms (VVCR).

The formulation with citric acid and sodium bicarbonate create a temporary physical barrier to oxygen inside the lumen of the vagina following the development of carbon dioxide (CO2), forming an anaerobic environment able to counteract the establishment, persistence or spread of a vaginal candida infection.

The presence of the two microorganisms Lactobacillus fermentum LF 10 and Lactobacillus acidophilus LA 02 reinforces the physical barrier action.

The slight effervescence carries the lactobacilli throughout the vaginal lumen, favoring their dispersion.

Components

One tablet contains: Citric acid. Sodium bicarbonate. Lactobacillus fermentum LF 10 (DSM 19187): no less than 400 million live lactobacilli. Lactobacillus acidophilus LA 02 (DSM 21717): no less than 400 million live lactobacilli. Fructo-oligosaccharides (FOS): 332 mg. Arabinogalactan; mg 273.

Ingredients

Microcrystalline cellulose. Anhydrous calcium hydrogen phosphate. Glyceryl behenate. Sucrose palmitate. Silicon dioxide (anti-caking agent). Magnesium stearate.

How to use

Candida vulvovaginitis (VVC): One vaginal tablet per day to be applied in the evening before bedtime. This treatment should be carried out for 5 days and then prolonged with one vaginal tablet every three days for the next three vaginal tablets.

Relapsing forms of Candida Vulvovaginitis (VVCR): One vaginal tablet every two days to be applied in the evening before bedtime. This treatment should be carried out for 10 days and then prolonged with one vaginal tablet a week for the next three vaginal tablets.

As a preventive measure, we recommend using one vaginal tablet a week for the next eight weeks. Do not take the product by mouth .